Table 3 Overall feasibility
Objective | Measurement | Progression threshold | Level achieved | Feasibility of domain |
|---|---|---|---|---|
Objective 1: Participants’ willingness to take part | Percentage of eligible participants randomised | ≥ 90% | 96.8% | Yes |
Objective 2: Appropriateness of eligibility criteria | Percentage of identified participants eligible | ≥ 60% | 14.1% | No |
Objective 3: Participant retention | Percentage of participants retained at follow-up | ≥ 80% | 83.3% | Yes |
Objective 4: Acceptability of interventions | a. Participant satisfaction with group allocation @ 7–10 on a 10-point scale | ≥ 75% | 75.0% | Yes |
b. Participant report of intervention acceptability @ 1–3 on a 7-point scale | ≥ 75% | 95.0% | Yes | |
Objective 5: Acceptability of assessments | a. Completeness of main outcomes data | ≥ 80% | 90.0% | Yes |
b. Participant report of assessment acceptability @ 1–3 on a 7-point scale | ≥ 90% | 92.0% | Yes | |
Objective 6: Utility of CardioSTAT® monitor | a. Participant report of monitor influence on participation @ 1–2 on a 5-point scale* | ≥ 50% | – | [Analysis unviable] |
b. Difference in the number of AF episodes each recorded by monitor and symptom diary | ≤ 1 episode difference | – | [Analysis unviable] | |
Objective 7: Participant experience of study participation | Participant report of overall participation acceptability | ≥ 75% | 96.0% | Yes |